[Cord blood transplantation with thiotepa containing myeloablative conditioning in a case of pediatric primary myelofibrosis]

Zhonghua Er Ke Za Zhi. 2022 May 2;60(5):471-473. doi: 10.3760/cma.j.cn112140-20210919-00809.
[Article in Chinese]

Abstract

1岁5月龄患儿以血常规三系减少、反复发热起病,肝脾进行性增大,骨髓病理提示造血细胞减少伴弥漫骨髓纤维化,排除恶性肿瘤等继发性原因,核型正常,无克隆异常,全外显子未检测出致病变异,未发现基因融合,诊断为原发性骨髓纤维化。脾切除术后,应用白消安、塞替哌为基础的清髓性预处理,脐带血造血干细胞移植成功。.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Cord Blood Stem Cell Transplantation*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Primary Myelofibrosis* / therapy
  • Thiotepa
  • Transplantation Conditioning

Substances

  • Thiotepa